Federal RuleAug 21
62
DOL Rewrites Disability Rules for 'Merit-Based Opportunity' Push
RuleLabor DepartmentFederal Contract Compliance Programs OfficeSignificant Wallet
116-hr-5882116th Congress
GENE Therapy Payment Act
Sponsored By: Representative Schrader, Kurt [D-OR-5]
Unknown
Summary
Generating Effective and Novel Evidence for Therapy Payment Act or the GENE Therapy Payment Act This bill allows state Medicaid programs to pay for certain gene therapy drugs through risk-sharing value-based payment agreements with drug manufacturers. The bill applies to covered outpatient drugs that provide potentially curative treatment for serious or life-threatening rare diseases or conditions after not more than three administrations.
Personalized for You
How does this bill affect your finances?
Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Bill Overview
No Economic Impacts Identified for this Bill
Sponsors & CoSponsors
Sponsor
Schrader, Kurt [D-OR-5]
OR • D
Cosponsors
Sen. Marshall, Roger [R-KS]
KS • R
Sponsored 2/12/2020
Rep. Crow, Jason [D-CO-6]
CO • D
Sponsored 2/12/2020
Rep. Mullin, Markwayne [R-OK-2]
OK • R
Sponsored 2/12/2020
Rep. Bera, Ami [D-CA-6]
CA • D
Sponsored 2/12/2020
Rep. Kelly, Mike [R-PA-16]
PA • R
Sponsored 2/12/2020
Rep. Schweikert, David [R-AZ-1]
AZ • R
Sponsored 2/12/2020
Roll Call Votes
No roll call votes available for this bill.
View on Congress.gov